Eric Tse is the Chief Executive Officer of Sino Biopharmaceutical Limited, one of Asia's most prominent life-science companies and the only Chinese-headquartered firm ranked seven consecutive years in Pharmaceutical Executive?s Global Top 50. With degrees from the Wharton School and Tsinghua University, he combines analytical rigor with a global perspective. Under his leadership, Sino Biopharm has accelerated innovation pipelines and expanded its therapies to reach 100 million+ patients worldwide. Alongside his corporate work, Eric is a globally engaged youth leader, with roles across the Global Shapers Community, the All-China Youth Federation, and multiple forums advancing cross-cultural dialogue and emerging-leader development.